News and Topics
Featured News
Public engagement is key to building momentum for longevity science, and you can make a real difference. Our nonprofit team works hard to bring you the latest news in the field. Please consider making a donation to support our work. Thank You.
In a new study, the popular supplement creatine seemed to add to some of the beneficial effects of power training [1]. Trying the
A new study has pit an advanced large language model against human physicians in tasks involving complex reasoning, treatment recommendations, and messy real-world
The Longevity Investor Network (LIN) was created to help bridge the gap between promising longevity startups and the investors capable of helping them
Aging is a multifaceted topic, and it’s becoming more and more clear that the only way to deal with it is piece by
A perspective published in Aging Cell details the replacement-based approaches being investigated by several research organizations. Repair versus replacement This perspective begins by
A recent study found an association between longer and more frequent daytime napping and higher mortality risk. The authors suggest using napping frequency
A new study calls for caution in using the well-known senolytic treatment of dasatinib and quercetin (D+Q), showing that it causes damage in
A new study has suggested that T cells might retain a pro-inflammatory phenotype long after normal weight is regained following a period of
A team of scientists has examined how younger and older mice heal from wounds and found that more robust senescent cell activation in
A new study has found that partial reprogramming mitigates the damage of myocardial infarction in mice by helping heart muscle cells to complete
For those of us in the Northern Hemisphere, spring is here. This is a time of renewal and hope for better times ahead,
Longevity Day at NFC Summit Lisbon has announced its confirmed speaker lineup ahead of its debut on 4 June 2026 at the Unicorn
An investigation into the aging immune system identified age-related changes, including sex-dependent differences, in immune cell subpopulations and gene expression. In general, females
According to a new study, rapamycin probably interferes with exercise, blunting its effects in older human subjects. This result, however, might be specific
BioAge Labs, Inc. (Nasdaq: BIOA) (“BioAge” or the “Company”), a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases by targeting the